Sandy Cove Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
Sandy Cove Advisors's LLY Position: Q2 2026 in Review
Sandy Cove Advisors increased its Eli Lilly (LLY) stake by 5.7% in Q2 2026, buying an estimated $126K and bringing the position to 2,284 shares worth $2.74M. The position accounts for 0.69% of the portfolio, ranked #28.
Sandy Cove Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,128 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sandy Cove Advisors held 2,284 shares of Eli Lilly worth $2.74M as of Q2 2026.
- Sandy Cove Advisors bought 123 Eli Lilly shares in Q2 2026, an estimated $126K.
- Eli Lilly made up 0.69% of Sandy Cove Advisors's portfolio in Q2 2026, its #28 holding.
- Sandy Cove Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 1,128 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.